We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimal Management of Women With Wrist Fractures

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00226031
First Posted: September 26, 2005
Last Update Posted: March 11, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by:
Queen's University
  Purpose
To evaluate the effectiveness of a multifaceted intervention (reminder and educational material) in improving the evaluation of osteoporosis follow-up care of post-menopausal women with wrist fractures by their primary care physicians. The intervention is directed at improving the gap in continuity of care between emergency/fracture clinics and family physicians, and reducing knowledge gaps.

Condition Intervention
Osteoporosis Osteopenia Procedure: Educational Material and Reminder

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Optimal Management of Older Women With Distal Forearm Fractures

Resource links provided by NLM:


Further study details as provided by Queen's University:

Primary Outcome Measures:
  • Proportion of women who are prescribed anti-osteoporosis therapy within 6 months of sustaining a forearm fracture. [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • Proportion of women in whom a bone density scan is ordered and the proportion of women who receive counseling advice about osteoporosis from their family physicians. [ Time Frame: 6 months ]
  • Women's knowledge about osteoporosis and fractures (Osteoporosis Knowledge Questionnaire). [ Time Frame: 6 months ]

Enrollment: 270
Study Start Date: September 2003
Study Completion Date: August 2007
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Usual care.
Procedure: Educational Material and Reminder
Family practices were randomly assigned to intervention or usual care. The intervention was a mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the GP and a letter and educational package for the women.
Experimental: 2
Mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the family physician and a letter and educational package for the women.
Procedure: Educational Material and Reminder
Family practices were randomly assigned to intervention or usual care. The intervention was a mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the GP and a letter and educational package for the women.

Detailed Description:

Numerous studies have demonstrated that women with wrist fractures have lower bone mineral density. Despite new guidelines for the care of such women, research has shown that they are not generally evaluated for osteoporosis. This care gap exists although it is known that wrist fractures are an important marker for subsequent fractures, such as a hip fracture, which represents a significant socio-economic burden to society.

Comparison: Cluster randomized trial of women and their physicians, both of whom receive educational material and reminder on post fracture osteoporosis evaluation. Comparison is to women and their physicians who receive standard post fracture information. Family practices are randomized to intervention or non-intervention group.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Postmenopausal women with low trauma distal radius fracture (confirmed by x-ray).
  2. Can be taking Didrocal (etidronate), Miacalcin (calcitonin),or hormone replacement therapy .

Exclusion Criteria:

  1. Women with fractures of the elbow, mid radius, scaphoid, or injury to wrists (without actual fracture).
  2. Significant cognitive impairment (which would preclude them from filling out simple questionnaires).
  3. Women already taking osteoporosis therapy, ie. either Fosamax (alendronate), Actonel (risedronate), or the selective estrogen receptor modulator, Evista (raloxifene).
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00226031


Locations
Canada, Ontario
Queen's University
Kingston, Ontario, Canada, K7L 3N6
Sponsors and Collaborators
Queen's University
Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: Ann B Cranney, MD Queen's University
  More Information

Responsible Party: Dr. Ann Cranney, University of Ottawa
ClinicalTrials.gov Identifier: NCT00226031     History of Changes
Other Study ID Numbers: KTS-62358
First Submitted: September 22, 2005
First Posted: September 26, 2005
Last Update Posted: March 11, 2015
Last Verified: March 2015

Keywords provided by Queen's University:
Osteoporosis
Wrist fractures
Knowledge translation
Implementation
Educational reminder

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases